Additional information
White Powder
39672-77-0
ACI-045015
236.2-237.2°C
C24H31BrO6
495.4
Ambient
2-8°C
Anti-inflammatory
Pharmaceutical Impurity Standards
(11?,16?)-9-bromo-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-Pregna-1,4-diene-3,20-dione
(11ß,?16a)?-9-?bromo-?11,?21-?dihydroxy-?16,?17-?[(1-?methylethylidene)?bis(oxy)?]?-?Pregna-?1,?4-?diene-?3,?20-?dione(Bromo desonide)
9-Bromo-11?,16?,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,17-Acetonide






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)